Filing Flows › Bausch Health Companies (BHC) › Guidance history
Bausch Health Companies (BHC) guidance history: what it guided and what it reported
Bausch Health Companies gave guidance in 12 earnings releases on file since Feb 22, 2024. Of 3 guided periods since reported, it met or beat its own guidance 3 times (100%). Revenue: 2 of 2, on average +0.8% against the guided midpoint. Its releases raised guidance 6 times and lowered it 0 times.
Revenue
Met or beat 2 of 2 periods (1 above, 1 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $10.6B–$10.9B (Feb 18, 2026) | — | to be reported | — |
| FY2025 | $9.9B–$10.2B (Feb 19, 2025) → raised $10.1B–$10.2B (Oct 29, 2025) | $10.3B | above the range | +1.1% |
| FY2024 | $9.3B–$9.6B (Feb 22, 2024) → reaffirmed $9.3B–$9.6B (May 2, 2024) → raised $9.4B–$9.7B (Aug 1, 2024) → raised $9.5B–$9.7B (Oct 30, 2024) | $9.6B | within the range | +0.4% |
GAAP net income
Met or beat 1 of 1 periods (1 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $112M (Feb 18, 2026) | — | to be reported | — |
| FY2025 | $93.0M (Feb 19, 2025) | $157M | above the range | +68.8% |
| FY2024 | $39.0M (Feb 22, 2024) | — | — | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.1B (Feb 18, 2026) | — | to be reported | — |
| FY2025 | $1.0B (Feb 19, 2025) → lowered $81.0M (Oct 29, 2025) | — | — | — |
| FY2024 | $869M (Feb 22, 2024) → raised $1.0B (May 2, 2024) → reaffirmed $1.0B (Aug 1, 2024) → reaffirmed $1.0B (Oct 30, 2024) | — | — | — |
Adjusted operating cash flow
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.0B (Feb 18, 2026) | — | to be reported | — |
| FY2025 | $1.0B (Feb 19, 2025) → reaffirmed $1.0B (Oct 29, 2025) | — | — | — |
The latest quarter
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart follows the revenue to costs, profit and cash.
Questions
Does Bausch Health Companies beat its guidance?
Bausch Health Companies gave guidance in 12 earnings releases on file since Feb 22, 2024. Of 3 guided periods since reported, it met or beat its own guidance 3 times (100%). Revenue: 2 of 2, on average +0.8% against the guided midpoint.
How often does Bausch Health Companies raise guidance?
Its earnings releases raised guidance 6 times and lowered it 0 times since Feb 22, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.